Scientific article
OA Policy
English

Medication adherence evaluated through electronic monitors during the 2020 COVID-19 pandemic lockdown in Switzerland: a longitudinal analysis

Published inPatient preference and adherence, vol. 16, p. 2313-2320
Publication date2022-08
First online date2022-08
Abstract

Background: During the 2020 COVID-19 lockdown, patients included in the Interprofessional Medication Adherence Program (IMAP) in Switzerland continued to use electronic monitors (EMs) that registered daily drug-dose intake. We aimed to understand to what extent patients’ medication implementation (ie, the extent to which the patient took the prescribed medicine), measured with EMs, was impacted by the lockdown.

Methods: Patients participating in the IMAP were diagnosed with diabetic kidney disease (DKD), solid cancer, human immunodeficiency virus (HIV) and miscellaneous long-term diseases (MLTD). Patient implementation was defined through a proxy: if all patient EMs were opened at least once daily, implementation was considered active (=1), and no implementation was considered (=0) otherwise. Implementation before (from December 2019 to March 2020), during (March to June 2020) and after (June to September 2020) the lockdown was compared. Subanalyses were performed according to the patients’ diseases. Subanalyses were performed in patients who used at least one EM in 2018– 2019 during the same periods (defined as winter, spring and summer). The logistic regression models used to estimate medication implementation according to the period were fitted using generalized estimating equations.

Results: In 2020, patient implementation (n = 118) did not differ significantly before versus during (OR = 0.98, 95% CI: 0.84– 1.15, p = 0.789) and before versus after (OR = 0.91, 95% CI: 0.79– 1.06, p = 0.217) the lockdown. These findings remained stable when separately analyzing the implementation of patients with HIV (n = 61), DKD (n = 25) or MLTD (n = 22). Too few patients with cancer were included (n = 10) to interpret the results. In 2019, the implementation of 61/118 (51.7%) patients was significantly lower during summertime versus wintertime (OR = 0.73, 95% CI: 0.60– 0.89, p = 0.002).

Conclusion: Medication implementation remained steady before, during and after the lockdown in 2020. The IMAP before, during and after the lockdown may have supported the adherence of most patients, by ensuring continuity of care during periods of routine disturbances.

Keywords
  • COVID-19
  • SARS-CoV-2
  • Electronic adherence monitoring
  • Implementation adherence
  • Interprofessional adherence intervention
  • Medication adherence
  • Patient compliance
Funding
  • Swiss Cancer Research foundation [HSR-4077-11-2016]
Citation (ISO format)
BANDIERA, Carole et al. Medication adherence evaluated through electronic monitors during the 2020 COVID-19 pandemic lockdown in Switzerland: a longitudinal analysis. In: Patient preference and adherence, 2022, vol. 16, p. 2313–2320. doi: 10.2147/PPA.S377780
Main files (1)
Article (Published version)
Identifiers
Journal ISSN1177-889X
158views
124downloads

Technical informations

Creation23/09/2022 07:48:00
First validation23/09/2022 07:48:00
Update16/03/2023 07:45:36
Status update16/03/2023 07:45:36
Last indexation01/11/2024 02:56:33
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack